首页> 外国专利> COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING TH1-MEDIATED IMMUNE DISEASE, TH17-MEDIATED IMMUNE DISEASE, OR TH2-MEDIATED IMMUNE DISEASE COMPRISING PEDIOCOCCUS PENTOSACEUS AS ACTIVE INGREDIENT

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING TH1-MEDIATED IMMUNE DISEASE, TH17-MEDIATED IMMUNE DISEASE, OR TH2-MEDIATED IMMUNE DISEASE COMPRISING PEDIOCOCCUS PENTOSACEUS AS ACTIVE INGREDIENT

机译:预防,改善或治疗TH1介导的免疫疾病,TH17介导的免疫疾病或TH2介导的免疫疾病的成分,包括PEDIOCOCCUS PENTOSACEUS作为有效成分

摘要

The present invention relates to a composition for preventing, ameliorating, or treating a Th1-mediated immune disease, a Th17-mediated immune disease, or a Th2-mediated immune disease, the composition comprising Pediococcus pentosaceus as an active ingredient. The Pediococcus pentosaceus of the present invention induces regulatory T cells; regulates the ratio of the immune tolerant cytokine (IL-10; anti-inflammatory cytokine) to the immune activating cytokine (IL-12); and effectively controls a Th1-mediated immune disease, a Th17-mediated immune disease or a Th2-mediated immune disease by reducing Th1-related cytokines, Th17-related cytokines and Th2-related cytokines in the production of immunoglobulin E (IgE) and immune hypersensitive response, and therefore has an advantage that can be used as an anti-allergic composition and an anti-inflammatory composition.
机译:本发明涉及用于预防,改善或治疗Th1介导的免疫疾病,Th17介导的免疫疾病或Th2介导的免疫疾病的组合物,该组合物包含戊糖小球菌(Pediococcus pentosaceus)作为活性成分。本发明的戊糖小球菌可诱导调节性T细胞。调节免疫耐受细胞因子(IL-10;抗炎细胞因子)与免疫激活细胞因子(IL-12)的比例;通过减少免疫球蛋白E(IgE)和免疫球蛋白生产中的Th1相关细胞因子,Th17相关细胞因子和Th2相关细胞因子,有效控制Th1介导的免疫疾病,Th17介导的免疫疾病或Th2介导的免疫疾病过敏反应,因此具有可以用作抗过敏组合物和消炎组合物的优点。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号